TrialOral oncology2011

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer.

Athanassios Argiris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.